1 Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, Rhode Island 02912; 2 Cell Based Delivery, Incorporated, Providence, Rhode Island 02906; and 3 Department of Pathology, Brown University Medical School/The Miriam Hospital, Providence, Rhode Island 02906
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Human bioartificial muscles (HBAMs) are tissue engineered by suspending muscle cells in collagen/MATRIGEL, casting in a silicone mold containing end attachment sites, and allowing the cells to differentiate for 8 to 16 days. The resulting HBAMs are representative of skeletal muscle in that they contain parallel arrays of postmitotic myofibers; however, they differ in many other morphological characteristics. To engineer improved HBAMs, i.e., more in vivo-like, we developed Mechanical Cell Stimulator (MCS) hardware to apply in vivo-like forces directly to the engineered tissue. A sensitive force transducer attached to the HBAM measured real-time, internally generated, as well as externally applied, forces. The muscle cells generated increasing internal forces during formation which were inhibitable with a cytoskeleton depolymerizer. Repetitive stretch/relaxation for 8 days increased the HBAM elasticity two- to threefold, mean myofiber diameter 12%, and myofiber area percent 40%. This system allows engineering of improved skeletal muscle analogs as well as a nondestructive method to determine passive force and viscoelastic properties of the resulting tissue.
muscle hypertrophy; viscoelasticity; tension; collagen gel; force transducer; organogenesis
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
DURING EMBRYOGENESIS, the development of human skeletal muscle is coordinated with the development of many different organ systems, especially the skeletal system. Many scientists believe bone elongation (~2 mm/wk during human embryogenesis) (2) directs the initial phases of muscle organogenesis (34). The continuous passive tension applied to skeletal muscle by bone growth during both embryogenesis and neonatal development influences muscle weight and length (34) and myofilament organization (19). A role for mechanical forces on skeletal muscle growth continues into adulthood. Stretch and exercise are responsible for many in vivo muscle adaptations after early development, including the regulation of protein synthesis and degradation rate (17, 18), total RNA and DNA content (14, 17, 34), and protein accumulation (17, 34). Increased work load or exercise changes mature muscle morphology by increasing both the number and diameter of muscle fibers (10, 20, 21, 23, 28). In addition, mechanical regulation of skeletal muscle responses to growth factors such as insulin sensitivity (12), heat shock protein 72 gene expression (11), and nitric oxide release (35) occur in vivo.
It has been shown that mechanical stimulation of tissue-cultured skeletal muscle cells causes changes similar to those seen when in vivo skeletal muscle is mechanically loaded. Studies have indicated that mechanical stimulation of monolayer skeletal muscle cultures affects gene regulation (5), endogenous protein expression (14, 32, 34), protein accumulation (39), protein localization (41), and metabolic activity (22) in a manner consistent with changes that occur in vivo. Mechanical stimulation also increases cellular proliferation (39), myofiber organization (6, 36, 41), and extracellular matrix (ECM) composition (41). Repetitive stretch/relaxation of avian and rodent skeletal muscle cells by patterns that simulate in vivo skeletal growth and exercise alters the structural organization of the constructs. Unidirectional stretch (36-40 h) followed by repetitive stretch (2-3 wk) of avian bioartificial muscles was shown to lengthen, orient, and organize the myofibers compared with static cultures (41). Stress loading also improves the orientation and density of rodent myofibers cultured in collagen gels (31).
Although these studies have shown improvements in structure and function of cultured avian and rodent muscle with mechanical stimulation, similar studies have not been reported for human skeletal muscle cells. Primary human skeletal muscle cells have been isolated from healthy adults and diseased populations, expanded in tissue culture, and statically tissue engineered into human bioartificial muscles (HBAMs) (M. Nackman, A. Lee, S. McGuire, J. Shansky, C. Powell, J. Hennessey, L. Krivickas, B. Biller, and H. Vandenburgh, unpublished observation; Ref. 33). These HBAMs are representative of in vivo skeletal muscle in that they contain a parallel array of fused postmitotic muscle fibers expressing sarcomeric contractile proteins. However, they fall short of actual skeletal muscle in many aspects, including small diameter muscle fibers, low myofiber density, and excessive ECM. To be used for structural/functional skeletal muscle repair or replacement, HBAMs need to be engineered with properties more similar to in vivo skeletal muscle. In an attempt to improve the structure of tissue engineered HBAMs, we designed a novel computer-controlled device to repetitively, mechanically load HBAMs during both formation and long-term development while recording real time forces in the micronewton (µN) to millinewton (mN) range. This report describes the new device, passive forces measured within tissue-engineered human skeletal muscle, and the morphological and viscoelastic changes observed with repetitive mechanical stimulation of the constructs.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The mechanical cell stimulator.
A mechanical cell stimulator device, version 4 (MCS4), was designed and
built to mechanically load six HBAMs grown in silicone rubber tissue
molds positioned in the wells of commercially available sixwell (35-mm
diameter) tissue culture dishes (Fig.
1A). Each well contains two 2-mm-diameter stainless steel pins suspended ~1 mm
off the bottom of each well and 20 mm apart, acting as artificial tendons for HBAM attachment. One pin in each well attaches to a stepper
motor, allowing for direct mechanical stimulation of HBAMs, and the
other pin is either immobile (four wells) or attaches to a force
transducer (two wells). A total of 5 mm of mechanical stretching, i.e.,
25% change in length, is possible before the end of the mold is
reached. National Instruments hardware (NU Drive 4SX-411 4-Axis Step
ValueMotion Drive, PC-STEP-4CX 4-Axis Closed Loop Step Controller)
drives a size 17 1.8° linear actuator stepper motor (Eastern Air
Devices) with linear accuracy of ~50 µm. LabVIEW software, National
Instruments' graphics-based programming tool, is used to coordinate
instrument control, data acquisition, and data presentation. A LabVIEW
virtual instrument allows the user to define unidirectional stretch
amplitude and velocity, repetitive stretch amplitude (which also may be
combined with unidirectional stretch amplitudes), velocity (up to 0.5 mm/s), pattern of stretch (number of stretch/relaxation per set and
number of sets/cycle), and duration of rest periods. An additional
feature of the MCS4 is that it contains sensitive force transducers
[Omega Scientific ultra-low capacity bending beam load cell, model
LCUB-002G, 2-g (20 mN) full-scale capacity, ~5 mg (50 µN)
sensitivity] attached to one end of two of the six HBAMs (LC in Fig.
1A). The force transducer is also controlled with LabVIEW
software and a National Instruments data acquisition board
(PCI-6023/24/25E) and signal conditioner (SCXI-1000). These force
transducers were calibrated by applying known loads to the transducers
with a force generator (8), reading the outgoing voltage,
and generating a calibration curve. Real-time passive force
measurements were made during HBAM formation and during mechanical
stimulation at a rate of up to 100 samples/s, averaging 100 samples/data point.
|
Dynamic tissue engineering of HBAMs. HBAMs were tissue engineered in a manner similar to that previously described (33). Cryopreserved primary human skeletal muscle cells isolated by needle biopsy from the vastus lateralis (33) of healthy adults ages 35-50 were thawed and expanded in 10-cm tissue culture dishes with myoblast growth medium [MGM: SkGM (Clonetics, catalog no. CC-3161) plus 15% (vol/vol) FBS (Sigma, catalog no. F2442)]. Biopsies were performed on volunteers according to procedures approved by the Institutional Clinical Review Board. Cells from four different biopsies were used in these studies and averaged 60-80% myogenic based on desmin positive staining. The cells were always used before 22 population doublings, a time after which growth and differentiation potential diminishes (33). After expansion, the cells were suspended by using trypsin/EDTA, pelleted by centrifugation at 800 g, and resuspended in chilled MGM containing 0.8 mg/ml type I rat tail collagen (Collaborative Biomedical Products, Bedford, MA, catalog no. 354236) neutralized with 10% (vol/vol) 0.15 N NaOH (1 × 106 cells/770 µl solution). MATRIGEL (Collaborative Biomedical Products, catalog no. 354234), a complex mixture of ECM proteins, growth factors, and glycosylaminoglycans produced by murine carcinoma cells, was added to the cell/collagen suspension at a ratio of 1:6 (vol/vol) MATRIGEL:collagen. The new cell/gel mixture was then carefully transferred into the silicone rubber molds of the MCS4 (900 µl/mold). After the HBAMs were cast, the MCS4 was placed in a humidified 37°C, 5% CO2 incubator, and, after 6 h, the wells were flooded with MGM (9 ml/well). The HBAMs were maintained in MGM for 3 days, fusion medium [FM: high glucose DMEM (GIBCO Life Science, catalog no. 11995-040) supplemented with 2% HS (Sigma, catalog no. H1270), pen (10 U/ml)] for 5 days, and then maintenance medium [MM: high glucose DMEM supplemented with 10% (vol/vol) HS, 5% (vol/vol) FBS, and pen (10 U/ml)] for the remainder of the experiment. Medium changes were made every 2-3 days for the length of the experiments (8-16 days). ECM gels without cells were used as controls.
Within 24 h after casting, the cell/gel mix had contracted and detached from the mold and was held in place only at the two attachment sites (Fig. 1B). In those experiments that included mechanical stimulation, unidirectional stretch began at 24 h, acting to simulate the bone growth that occurs during embryogenesis. The HBAMs were stretched 500 µm/day for 4 days. The stretch occurred in step intervals of ~3.5 µm every 10 min (total unidirectional stretch over 4 days of 10% of initial length). A similar unidirectional pattern aligned fusing avian myoblasts grown on an elastic substratum into organized myofibers (41). The HBAMs were held at the new extended length for 3 days. Repetitive stretch/relaxation similar to a pattern found to cause skeletal muscle hypertrophy in monolayer avian skeletal muscle cultures (39) then began on day 8 postcasting. The stretch pattern consisted of three sets of five stretch/relaxations. Each set was separated by ~30 s of rest, with 28 min of rest after the third set; thus each cycle lasted ~30 min (Fig. 1C). The HBAMs were stretched at 5% strain (1 mm) for 2 days (days 8-10), 10% strain (2 mm) for 2 days (days 10-12), and 15% strain (3 mm) for 4 days (days 12-16). HBAMs that were not repetitively strained were used as controls.Measurement of cell-generated passive force. The sensitive force transducer connected to the pin around which the HBAM formed was used for isometric force measurements. HBAMs were cast in the MCS4 silicone rubber tissue molds, and real-time sampling of the passive force within nonmechanically stimulated and mechanically stimulated HBAMs was recorded for up to 16 days. ECM gels without cells were used as controls. To determine whether the passive tension in HBAMs was related to the cell's cytoskeleton, HBAMs were treated with an actin depolymerizer (cytochalasin D). Previous work in other laboratories (7, 25) has shown that passive fibroblast force generation in a collagen matrix is attenuated by disrupting the actin filaments. Because this attenuation was reversible when the pharmacological agent was washed out, we also studied reversibility. Nine days after casting, control (nonmechanically stimulated) HBAMs were rinsed with serum-free medium and incubated with 2-5 µM cytochalasin D (Sigma, catalog no. C8273) in serum-free maintenance medium. An injection port in the cover of the MCS4 device allowed for solution exchange without removing the device from the incubator or exposing the force transducers and HBAMs to changes in temperature and humidity. When the cytochalasin D HBAM response plateaued (~3 h), the HBAMs were rinsed with Earle's balanced salt solution (EBSS), fresh serum-free medium without cytochalasin D was added for 1 h, and then serum-containing maintenance medium was added for 24 h. Passive forces were recorded every 10 min by using the Omega force transducers and LabVIEW software.
To determine the internal stresses elicited by step stretching, control (nonmechanically stimulated) HBAMs were stretched to 5, 10, and 15% strain and held at this strain for 10 min before returning to the culture length (0% strain). After 10 min at the culture length, the strain routine was repeated for a total of four step stretches. Force measurements were recorded immediately after the stretch and every minute for the duration of the experiment.Measurement of HBAM viscoelastic properties. The MCS4 device was used to measure HBAM nonfailure material properties of HBAMs mechanically conditioned from day 8 to day 16 postplating by the pattern shown in Fig. 1C. After 0, 2, 6, and 8 days of repetitive mechanical conditioning, the stretch pattern was paused and the HBAMs were stretched at a rate of 5% strain/min until their tension increased to 2,500 µN and then relaxed to their original length. Passive force was recorded every 250 ms during the testing. This pattern was repeated five to six times with a 10-min rest between tests. After material testing, the repetitive conditioning stretch/relaxation pattern was restarted and applied until the next testing day. The average elastic modulus was calculated by averaging the slope at each point along the ascending portion of the stress/strain hysteresis and compared with time-matched static control HBAMs.
Immunocytochemical staining. For whole mount sarcomeric tropomyosin staining, HBAMs were fixed with 4% formalin followed by Dent's fixative (1 part DMSO/4 parts 100% ethanol). Localization of sarcomeric tropomyosin was visualized by an overnight incubation with mouse antitropomyosin (Sigma, catalog no. T9283), followed by biotinylated anti-rabbit IgG secondary antibody, avidin-biotinylated reagent coupled to horseradish peroxidase (Vector Laboratories, Burlington, CA, catalog no. PK-6101) and developed with 3,3'-diaminobenzidine (DAB) (Sigma, catalog no. D5905). HBAMs were also stained and visualized in cross section to determine the effect of mechanical stimulation on HBAM morphology. HBAMs were fixed in 4% formalin, and a portion of the formalin fixed HBAM was paraffin embedded and sectioned in 5-µm cross sections. The paraffin cross sections were deparaffinized and then gradually rehydrated from 100% ethanol to dH2O. The slides were stained with an antibody to myosin heavy chain (Sigma, catalog no. M4276) followed by incubation with a biotinylated anti-mouse IgG secondary antibody, avidin-biotinylated reagent coupled to horseradish peroxidase, and developed with DAB. Sections not incubated with biotinylated secondary antibody were used as negative controls. These procedures are detailed in Powell et al. (33).
Image analysis. Stained sections were photographed at various magnifications using a Sony charge-coupled device (CCD) color video camera (DXC-970MD) attached to a Zeiss microscope. The Zeiss KS300 3.0 Image Analysis Software package was used to measure HBAM cross-sectional area, myofiber diameter, and percent HBAM cross-sectional area occupied by myofibers. The software calculated myofiber area percent by dividing the area occupied by myofibers from the total cross-sectional area.
Statistical analysis. Each experiment was performed with at least three HBAMs in each experimental group and repeated in at least two independent experiments. All data are presented as means ± SE. We analyzed the data using the Student's t-test (SigmaStat software, Jandel Scientific). Differences were statistically significant with P < 0.05.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Morphological changes with mechanical stimulation.
Primary human skeletal muscle cells were initially tissue engineered
into HBAMs by suspending the cells in a collagen/Matrigel ECM solution
and casting into silicone rubber molds. Internal longitudinal tensions
developed within the cell/gel mixture as it dehydrated, causing the
formation of a cylindrical HBAM (Fig. 1B). Gel dehydration
and detachment from the molds did not occur in the absence of cells
(data not shown). The internal longitudinal tensions were adequate to
align the human myoblasts into parallel arrays which then fused into
aligned multinucleated myofibers (Fig.
2A). Sarcomeric myosin
staining of these statically formed HBAMs indicated that only
2-10% of their cross-sectional area comprised muscle fibers (Fig.
2B) with fiber diameters <10 µm by 16 days in tissue
culture. In an attempt to improve our tissue-engineering techniques, we
mechanically stimulated the HBAMs, simulating forces associated with
muscle organogenesis and exercise. Mechanical conditioning of HBAMs
improved HBAM myofiber diameter and area percentage (Fig.
3). After 8 days of repetitive
stimulation, the mean myofiber diameter significantly increased by 12%
from 6.4 to 7.1 µm (P < 0.05, n = 3-4 HBAMs, >2,000 myofibers measured), whereas the myofiber area
percent increased by 40% from 7.8 to 10.9% (P < 0.05, n = 3-4 HBAMs, 8-10 cross sections).
|
|
Passive tension measurements.
At 6-24 h after casting, the collagen gel dehydrated, causing the
HBAMs to detach from the silicone rubber tissue mold and become
attached only at the two end attachment sites. This creates cell-generated passive tensions within the cell/gel matrix. The Omega
ultra-low capacity bending beam load cell measured the passive tension
generated by HBAMs through several weeks in culture (Fig. 4). Noncell controls did not detach from
the molds or generate any passive tension. However, when maintaining
the HBAMs with attached force sensors at 37°C in an 80% humidified
CO2 incubator, transducer drift jumps in the transducer
signal due to changing the tissue culture medium (arrows in Fig. 4),
and other unpredictable events, e.g., incubator door openings, made it
difficult to completely characterize the passive tension
nondestructively in real time. A perfusion system is under development
to reduce these problems. The passive tension at the termination of the
experiment was determined by detaching the HBAM from the force
transducer and allowing the force reading to return to zero; if the
transducer reading after HBAM removal was nonzero, this value was
subtracted to obtain the HBAM's final passive tension measurement.
HBAMs typically generated 500-1,000 µN of passive tension per
106 cells, and no passive tension was generated in the
absence of cells in the gel (Fig. 4). To determine the potential
involvement of the cytoskeleton in passive tension, 9-day-old HBAMs
were exposed to an actin depolymerizer, cytochalasin D (2-5 µM),
in serum-free medium. Passive tension decreased 57 ± 2% over a
3-h incubation at 37°C, with the majority of tension decreasing
within the first hour (Fig. 5). After the
cytochalasin D was rinsed out, the tension quickly increased in
serum-containing medium, leveling off at 66 ± 3% of the original
tension. No increase in tension was seen after an hour in serum-free
medium (Fig. 5). These results suggest that the passive tension
development in the HBAMs is in part related to the cell's cytoskeleton
and that the reestablishment of that tension after depolymerization is
enhanced by undefined serum factors present in the medium.
|
|
|
|
Material property measurements.
The elastic modulus of HBAMs mechanically conditioned for 8 days from
day 8 to day 16 in vitro vs. control HBAMs
cultured statically for 16 days was determined using nonfailure testing methods as outlined in MATERIALS AND METHODS. Mechanically
conditioned HBAMs were found to be more elastic than static HBAMs (Fig.
8). The elastic modulus of control HBAMs
increased over time, whereas the elastic modulus of mechanically
conditioned HBAMs stayed constant so that, by day 16, there
was a two- to threefold difference between the two groups.
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
HBAMs can be tissue engineered by suspending primary human muscle cells in a collagen/MATRIGEL ECM. These tissue-engineered muscle constructs resemble in vivo muscle in that they contain parallel arrays of postmitotic muscle fibers (33). However, the morphology of static HBAMs is different from adult in vivo skeletal muscle in several ways. Whereas adult skeletal muscle fiber diameters range from 10 to 100 µm (4, 24), static HBAM muscle fiber diameters range from 3 to 25 µm with a mean of ~5 µm (Fig. 3). Because muscle fiber hypertrophy occurs during development and exercise training (24, 34), we predicted that repetitive stretching in vitro HBAMs might increase myofiber diameter, as was the case with mechanical stimulation of avian myofiber monolayers (39). To improve HBAM morphology, we designed and built a mechanical cell stimulator (MCS4) to add mechanical loading to the three-dimensional tissue-engineering procedure. The MCS4 was designed to stretch BAMs in a manner that stimulates muscle growth by simulating in vivo long bone growth during embryogenesis and the repetitive muscle loading of exercise. We chose to initially concentrate on a pattern of mechanical loading similar to one that stimulated myofiber hypertrophy in avian myofibers (39) and investigated the effect of this stimulus on myofiber diameter and myofiber area percent. Mechanical conditioning was found to increase mean HBAM myofiber diameter by 12% after 8 days of mechanical stimulation (Fig. 3). The resultant 12% myofiber hypertrophy in HBAMs was comparable to the 16% observed in avian BAMs (39) and to the 10-17% fiber hypertrophy after 12 wk of resistance training in healthy adults (28); however, this in vitro hypertrophy did not increase the myofiber diameter to approach the in vivo skeletal muscle range of 10 to 100 µm. One reason for the small myofiber size may be the lack of innervation. In humans, denervated adult myofibers atrophy to an ~20-µm mean diameter (30) compared with ~50-µm mean diameter in innervated muscle. Appropriate growth factors/cofactors and other nutrients may be missing from the tissue culture medium and may also contribute to the small size of the tissue-engineered muscle fibers.
The myofiber distribution of static HBAMs also has limited resemblance to adult skeletal muscle. In vivo skeletal muscle contains closed-packed fibers organized in fasciculi distributed throughout the tissue; HBAMs contain widely dispersed myofibers throughout the construct (Fig. 2). Approximately 90% of in vivo muscle is occupied by muscle fibers (28), whereas only 2-15% of our tissue-engineered (control and mechanically stimulated) HBAMs is occupied by muscle fibers (Fig. 3). The remaining area is ECM. It is likely that the HBAM morphology is a result of poor oxygenation and nutrient availability in the HBAM core because they are avascular. It is generally accepted that cells do not survive unless they are within 250-300 µm from their nutrient source (13). Mechanical stimulation improves the area percent myofibers by 40%, possibly by enhancing nutrient diffusion through the ECM. Average HBAM diameter also decreases during the stretching phase (due to increased length and conservation of volume), which may also allow nutrient penetration to the interior of the structure. Nutrients that have penetrated the HBAM may be pushed toward the center of the construct with mechanical perturbation.
With the use of a stretching pattern that stimulates hypertrophy in in vitro avian skeletal muscle, HBAMs demonstrate significant increases in both myofiber diameter and myofiber density. These changes are in the right direction to improve HBAM morphology but are still far removed from in vivo skeletal muscle. Further improvements may be possible by changing the mechanical stimulation pattern or improving the ECM that the constructs are engineered with. Furthermore, skeletal muscle growth and hypertrophy is known to be due to an interaction of nutrition, hormones, innervation, and exercise (37), and, therefore, a combination of these other factors may be critical for inducing more substantial changes and engineering HBAMs with the necessary structural and functional characteristics for use as repair or replacement skeletal muscle. Future experiments will address these factors.
Many studies have investigated the internal passive tension of cells plated on or in a collagen matrix. A number of recent studies have found that passive tension can be attributed to the cells' acting on the gel to generate the passive forces (7, 9). The primary human muscle cells used in the present work caused gel contraction and dehydration as previously observed with avian and rodent muscle cells (38, 40). This suggests that HBAMs are under passive tension in their normal tissue-cultured state. Fibroblasts grown in a collagen matrix generate passive tensions which have been quantitated. During the first 6-36 h after plating, the cell/gel mixture rapidly contracts, generating forces in the range of 0.1 and 1.0 g (1,000-10,000 µN) per 106 cells, depending on the cell source (7, 25, 27). The Omega load cell in the MCS4 allowed measurement of the passive tension at intermittent time points over days to weeks in the CO2 incubator; ~100 mg (1,000 µN) of tension/106 cells were found to develop over the first 3 days after plating (Fig. 4). Perturbations in the force readings corresponding to culture medium changes (possibly due to disconnecting the electrical wires necessary for the force readings, a temporary change in the cells' environment when removed from the incubator, or mechanical perturbation of the force transducer) prevented us from making reliable, real-time, long-term measurements with this set up. Other groups have not reported similar problems, but their data was collected for <4 days, and, therefore, culture medium changes appear to not have been performed. Real-time, long-term measurements were not obtained; however, the tension at the end point of each experiment was obtained by determining the drift of the transducers, allowing us to compare the passive force in HBAMs to those of other tissue-engineered constructs. Although we were able to compare the passive tension in HBAMs to that in other cell/gel constructs based on tension per cell number, we were unable to directly compare it to other tissue-engineered skeletal muscle constructs (i.e., myooids; Refs. 8 and 26) because passive tensions in those studies were not normalized to cell number. HBAMs and myooids do have similar passive tension when normalized for cross-sectional area (~2 mN/mm2 in HBAMs compared with 0.8 to 6 mN/mm2 in rodent myooids; Refs. 8 and 26). A primary goal for future research is to develop more robust force transducers for tissue-engineering purposes.
In 1979, Bell attributed the passive tension in cell/gel structures to cells pulling against the collagen fibrils (1). Recent data more specifically connect the tension in fibroblast-contracted gels to the cellular cytoskeleton (3, 7, 25). Cytoskeleton disruption with pharmacologic agents such as colcemid (7), cytochalasin B (7), and cytochalasin D (25) resulted in 100% decrease in passive tension. When HBAMs were treated with cytochalasin D, the force measurements rapidly decreased ~70%, supporting a role for the cytoskeleton in passive force. A higher concentration or longer period of incubation with cytochalasin D may be required for complete cytoskeletal disruption and 100% loss of passive tension in the HBAMs. Also, other components in the cells or their matrix (e.g., microtubules, actin-myosin sarcomeric structure, collagen gel, or MATRIGEL) may be responsible for a portion of the HBAM passive tension.
Nonfailure tensile testing of HBAMs showed that mechanically conditioned HBAMs maintained a constant elastic modulus over 8 days of stretching (day 8 to day 16 in vitro), whereas control HBAMs become stiffer (Fig. 8). Girton et al. (15, 16) showed that static collagen gels containing smooth muscle cells also become stiffer with time in culture. Their studies attribute the stiffening to collagen cross linking. It is possible that the repetitive stretch/relaxation cycles inhibit collagen cross-linking in HBAMs. It is also likely that fibroblasts in the HBAMs are remodeling the ECM in response to the repetitive mechanical loading in a different fashion to their remodeling in statically grown HBAMs. As the HBAMs become more elastic with mechanical stimulation, it will be necessary to change the stretch amplitude to impose a desired load. Our ability to predict and measure the tissue viscoelastic properties and the load applied to the engineered tissue will allow us to improve our dynamic engineering techniques to engineer HBAMs with improved morphology that will be useful in the future for a number of applications, including structural repair, drug screening, and gene therapy.
![]() |
ACKNOWLEDGEMENTS |
---|
This work was supported by grants from the National Institute on Aging R01-AG-15415, R44-AG-14958, National Aeronautics and Space Administration NAG2-1205, and National Institute of Standards and Technology ATP 70NANB9H3011.
![]() |
FOOTNOTES |
---|
Address for reprint requests and other correspondence: H. H. Vandenburgh, Cell Based Delivery, Inc., 4 Richmond Square, 5th Fl., Providence, RI 02906 (E-mail: Herman_Vandenburgh{at}Brown.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
July 17, 2002;10.1152/ajpcell.00595.2001
Received 20 December 2001; accepted in final form 17 June 2002.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Bell, E,
Ivarsson B,
and
Merrill C.
Production of tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro.
Proc Natl Acad Sci USA
76:
1274-1278,
1979[Abstract].
2.
Bernstein, IM,
Plociennik K,
Stahle S,
Badger GJ,
and
Secker-Walker R.
Impact of maternal cigarette smoking on fetal growth and body composition.
Am J Obstet Gynecol
183:
883-886,
2000[ISI][Medline].
3.
Brown, RA,
Talas G,
Porter RA,
McGrouther DA,
and
Eastwood M.
Balanced mechanical forces and microtubule contribution to fibroblast contraction.
J Cell Physiol
169:
439-447,
1996[ISI][Medline].
4.
Burkitt, HG,
Young B,
and
Heath JW.
Muscle.
In: Wheater's Functional Histology. New York: Churchill Livingstone, 1995, p. 93-103.
5.
Carson, JA,
and
Booth FW.
Effect of serum and mechanical stretch on skeletal -actin gene regulation in cultured primary muscle cells.
Am J Physiol Cell Physiol
275:
C1438-C1448,
1998
6.
Collinsworth, AM,
Torgan CE,
Nagda SN,
Rajalingam RJ,
Kraus WE,
and
Truskey GA.
Orientation and length of mammalian skeletal myocytes in response to a unidirectional stretch.
Cell Tissue Res
302:
243-251,
2000[ISI][Medline].
7.
Delvoye, P,
Wiliquet P,
Leveque JL,
Nusgens B,
and
Lapiere C.
Measurement of mechanical forces generated by skin fibroblasts embedded in a three-dimensional collagen gel.
J Invest Dermatol
97:
898-901,
1991[Abstract].
8.
Dennis, RG,
and
Kosnik IIPE
Excitability and isometric contractile properties of mammalian skeletal muscle constructs engineered in vitro.
In Vitro Cell Dev Biol
36:
327-335,
2000[ISI].
9.
Eastwood, M,
Mudera VC,
McGrouther DA,
and
Brown RA.
Effect of precise mechanical loading on fibroblast populated collagen lattices: morphological changes.
Cell Motil Cytoskeleton
40:
13-21,
1998[ISI][Medline].
10.
Etamadi, AA,
and
Hosseini F.
Frequency and size of muscle fibers in athletic body build.
Anat Rec
162:
269,
1968[ISI][Medline].
11.
Febbraio, MA,
and
Koukoulas I.
HSP72 gene expression progressively increases in human skeletal muscle during prolonged, exhaustive exercise.
J Appl Physiol
89:
1055-1060,
2000
12.
Felig, P.
Effects of exercise and physical training on field utilization, insulin sensitivity, and insulin secretion.
In: Frontiers of Exercise Biology. Champaign, IL: Human Kinetics, 1983, p. 186-197.
13.
Folkman, J,
and
Hochberg M.
Self-regulation of growth in three dimensions.
J Exp Med
138:
745-753,
1973[ISI][Medline].
14.
Frenette, J,
and
Tidball JG.
Mechanical loading regulates expression of talin and its mRNA, which are concentrated at myotendinous junctions.
Am J Physiol Cell Physiol
275:
C818-C825,
1998[Abstract].
15.
Girton, TS,
Oegema TR,
Grassl ED,
Isenberg BC,
and
Tranquillo RT.
Mechanisms of stiffening and strengthening in media-equivalents fabricated using glycation.
J Biomech Eng
122:
216-223,
2000[ISI][Medline].
16.
Girton, TS,
Oegema TR,
and
Tranquillo RT.
Exploiting glycation to stiffen and strengthen tissue equivalents for tissue engineering.
J Biomed Mater Res
46:
87-92,
1999[ISI][Medline].
17.
Goldspink, DF,
Cox VM,
Smith SK,
Eaves LA,
Osbaldeston NJ,
Lee DM,
and
Mantle D.
Muscle growth in response to mechanical stimuli.
Am J Physiol Endocrinol Metab
268:
E288-E297,
1995
18.
Goldspink, DF,
Easton J,
Winterburn SK,
Williams PE,
and
Goldspink GE.
The role of passive stretch and repetitive electrical stimulation on preventing skeletal muscle atrophy while reprogramming gene expression to improve fatigue resistance.
J Card Surg
6:
218-224,
1991[ISI][Medline].
19.
Goldspink, G.
The Physiology and Biochemistry of Muscle as a Food, Madison: University of Wisconsin, 1970, vol. 2, p. 27.
20.
Goldspink, G.
Alterations in myofibril size and structure during growth, exercise, and changes in environmental temperature.
In: Handbook of Physiology. Skeletal Muscle. Bethesda, MD: Am. Physiol. Soc, 1983, sect. 10, chapt. 18, p. 539-554.
21.
Gollnick, PD,
Armstrong RB,
Saubert IVCW,
Piehl K,
and
Saltin B.
Enzyme activity and fiber composition in skeletal muscle of untrained and trained men.
J Appl Physiol
33:
312-319,
1972
22.
Hatfaludy, S,
Shansky J,
and
Vandenburgh HH.
Metabolic alterations induced in cultured skeletal muscle by stretch/relaxation activity.
Am J Physiol Cell Physiol
256:
C175-C181,
1989
23.
Ianuzzo, CD,
Gollnick PD,
and
Armstrong RB.
Compensatory adaptation of skeletal muscle fiber types to a long-term functional overload.
Life Sci
19:
1517-1524,
1976[ISI][Medline].
24.
Junqueira, LC,
Carneiro J,
and
Kelley Muscle Tissue RO.
Basic Histology. Stamford: Appleton and Lange, 1995, p. 181.
25.
Kolodney, MS,
and
Wyss D.
Isometric contraction by fibroblasts and endothelial cells in tissue culture: a quantitative study.
J Cell Biol
117:
73-82,
1992[Abstract].
26.
Kosnik, PE,
Faulkner JA,
and
Dennis RG.
Functional development of engineered skeletal muscle from adult and neonatal rats.
Tissue Engineering
7:
573-584,
2001[ISI][Medline].
27.
Lambert, CA,
Soudant EP,
Nusgens BV,
and
Lapière CM.
Pretranslational regulation of extracellular matrix macromolecules and collagenase expression in fibroblasts by mechanical forces.
Lab Invest
66:
444-451,
1992[ISI][Medline].
28.
McCall, GE,
Byrnes WC,
Dickinson A,
Pattany PM,
and
Fleck SJ.
Muscle fiber hypertrophy, hyperplasia, and capillary density in college men after resistance training.
J Appl Physiol
81:
2004-2012,
1996
30.
Neumeyer, C,
Happak W,
Kern W,
and
Gruber H.
Hypertrophy and transformation of muscle fibers in paraplegic patients.
Artif Organs
21:
188-190,
1997[ISI][Medline].
31.
Okano, T,
and
Matsuda T.
Hybrid muscular tissues: preparation of skeletal muscle cell-incorporated collagen gels.
Cell Transplant
6:
109-118,
1997[ISI][Medline].
32.
Perrone, CE,
Fenwick-Smith D,
and
Vandenburgh HH.
Collagen and stretch modulate autocrine secretion of insulin-like growth factor-1 and insulin-like growth factor binding proteins from differentiated skeletal muscle cells.
J Biol Chem
270:
2099-2106,
1995
33.
Powell, C,
Shansky J,
DelTatto M,
Forman DE,
Hennessey J,
Sullivan K,
Zielinski BA,
and
Vandenburgh HH.
Tissue engineered human bioartificial muscles expressing a foreign recombinant protein for gene therapy.
Hum Gene Ther
10:
565-577,
1999[ISI][Medline].
34.
Stewart, DM.
The role of tension in muscle growth.
In: Regulation of Organ and Tissue Growth. New York: Associated Press, 1972, p. 77-100.
35.
Tidball, JG,
Lavergne E,
Lau KS,
Spencer MJ,
Stull JT,
and
Wehling M.
Mechanical loading regulates NOS expression and activity in developing and adult skeletal muscle.
Am J Physiol Cell Physiol
275:
C260-C266,
1998
36.
Vandenburgh, HH.
Dynamic mechanical orientation of skeletal myofibers in vitro.
Dev Biol
93:
438-443,
1982[ISI][Medline].
37.
Vandenburgh, HH.
Motion into mass: how does tension stimulate muscle growth.
Med Sci Sports Exerc
19:
S142-S149,
1987[ISI][Medline].
38.
Vandenburgh, HH,
Del Tatto M,
Shansky J,
LeMaire J,
Chang A,
Payumo F,
Lee P,
Goodyear A,
and
Raven L.
Tissue engineered skeletal muscle organoids for reversible gene therapy.
Hum Gene Ther
7:
2195-2200,
1996[ISI][Medline].
39.
Vandenburgh, HH,
Hatfaludy S,
Karlisch P,
and
Shansky J.
Skeletal muscle growth is stimulated by intermittent stretch/relaxation in tissue culture.
Am J Physiol Cell Physiol
256:
C674-C682,
1989
40.
Vandenburgh, HH,
Karlisch P,
and
Farr L.
Maintenance of highly contractile tissue-cultured avian skeletal myotubes in collagen gel.
In Vitro
23:
51,
1987.
41.
Vandenburgh, HH,
Swasdison S,
and
Karlisch P.
Computer aided mechanogenesis of skeletal muscle organs from single cells in vitro.
FASEB J
5:
2860-2867,
1991